Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acyclovir in HIV/HSV-2 Co-Infected Women
NCT00362596Phase 4Completed
- Sponsor
- Centers for Disease Control and Prevention
- Start
- Jan 2005
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of aciclovir in Genital Herpes Simplex (2 arms), sponsored by Centers for Disease Control and Prevention. Primary endpoint: Effect of acyclovir suppressive therapy on HIV genital shedding. Started Jan 2005; status: completed.
02
Drugs
aciclovir
03
Conditions
Genital Herpes Simplex
Beyond the preview
Go deeper on NCT00362596.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00362596.